Senate committee reccommends medical cannabis bill

cannabis plant with hand touching

A parliamentary committee is backing a plan by a cross-section of senators to make medical cannabis available to Australians.

The Senate's legal and constitutional affairs committee recommended the Greens bill to set up a regulator of medical cannabis be passed.

The regulator would be "responsible for formulating rules for licensing the production, manufacture, supply, use, experimental use and import and export of medicinal cannabis".

The committee unanimously recommended the bill's passage, with amendments to ensure scientific evidence is accessed to determine suitably of treatments.

It also wants amendments to ensure medical cannabis products are made available in Australia in line with international obligations.

The private bill is co-sponsored by government senator Ian MacDonald, Labor senator Anne Urquhart and Liberal Democratic Party senator David Leyonhjelm.

Greens leader Richard Di Natale said Australians wanted medical cannabis reform and hopes the support from all sides of politics means parliament can work together to make it happen.

"This issue is not about politics, it's about getting medicine to people who need it," he said.


Israeli Anti-Drug Authority Being Disbanded

Israeli Anti-Drug Authority
The Israeli Anti-Drug and Alcohol Authority, the Israel equivalent to the U.S. Drug Enforcement Administration (DEA), is being shut down in what the government is calling a cost-cutting move.

The agency has gained a large amount of criticism over its draconian stance on cannabis. The group recently ran an ad campaign warning that cannabis is...

Read more ...

Alan Jones – Lucy Haslam

lucy haslam talks to alan jones
  Alan Jones talks to Lucy Haslam
Alan talks to the medicinal cannabis advocate Lucy Haslam (Dan Haslam's mum) as a Senate committee prepares to report on the issue today.
Listen at Lucy Haslam talks to Alan Jones on 2GB
It will be interesting what comes frm the Senate committee.

FDA Gives Fast Track Approval to Cannabis Medicine for Newborns

newborn cannabis medicine
GW Pharmaceuticals, a biopharmaceutical company with a focus on cannabinoid-based medicines, has received fast track approval from the U.S.Food and Drug Administration (FDA) for a medicine designed to treat newborns deprived of oxygen during childbirth, which can lead to brain damage and deat

The FDA gave approval to an intravenous form of...

Read more ...